Blocking key enzyme to protect against fatty liver may raise cancer risk insteadBlocking key enzyme to protect against fatty liver may raise cancer risk instead
Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead increase the risk of chronic liver damage and cancer as we age.
Trump Talks About Taking GLP-1s; New MiniMed System OK’d; Testosterone in Diet RecsTrump Talks About Taking GLP-1s; New MiniMed System OK’d; Testosterone in Diet Recs
(MedPage Today) — President Trump said he’s never taken GLP-1 receptor agonists but said he “probably should.” (New York Times) People with diabetes and cancer lived longer and had lower hospitalization rates if they were taking GLP-1 drugs rather… (MedPage Today) — President Trump said he’s never taken GLP-1 receptor agonists but said he Read More
Serena Williams on Taking a GLP-1: ‘I Feel Like I’m Back’Serena Williams on Taking a GLP-1: ‘I Feel Like I’m Back’
The G.O.A.T. says we shouldn’t be shamed about what helps us feel better in our bodies. The G.O.A.T. says we shouldn’t be shamed about what helps us feel better in our bodies.
ACS Annual Statistics Report: Milestone 70 Percent 5-Year Survival Rate for all Cancers Combined; Largest Gains for Advanced and Fatal CancersACS Annual Statistics Report: Milestone 70 Percent 5-Year Survival Rate for all Cancers Combined; Largest Gains for Advanced and Fatal Cancers
This report marks the 75th year American Cancer Society researchers have analyzed and disseminated cancer data to help improve public health
Genetic Predisposition to Excess Body Weight and Breast Cancer SurvivalGenetic Predisposition to Excess Body Weight and Breast Cancer Survival
This cohort study investigates whether there is an association between a genetic predisposition to a greater body mass index and mortality risk among US women who survived nonmetastatic breast cancer.
New vulnerability identified in aggressive breast cancerNew vulnerability identified in aggressive breast cancer
Researchers at University of California San Diego have identified a previously unrecognized treatment target for triple‑negative breast cancer (TNBC), the most aggressive subtype of breast cancer. Their new study reveals that a protein called PUF60 plays an essential role in helping TNBC cells grow and survive by controlling how key genes are spliced.
Navigating Options After CDK4/6 Inhibition in Metastatic Breast CancerNavigating Options After CDK4/6 Inhibition in Metastatic Breast Cancer
(MedPage Today) — Clinicians treating patients with estrogen receptor (ER)-positive/HER2-negative metastatic breast cancer are navigating increasingly complex sequencing decisions in the post-CDK4/6 inhibitor setting, with antibody-drug conjugates…
How aggressive breast cancer controls protein productionHow aggressive breast cancer controls protein production
A previously unknown mechanism that makes it possible for aggressive so-called triple-negative breast cancer to fine-tune its production of proteins has been discovered by researchers at Umeå University, Sweden. The discovery increases our understanding of how tumors grow and adapt, and it opens up research into new future treatments. The study is published in Cancer Letters.
Supplement Tied to Stroke Risk; Cheese Recall Is Most Serious; GLP-1 Pioneer DiesSupplement Tied to Stroke Risk; Cheese Recall Is Most Serious; GLP-1 Pioneer Dies
(MedPage Today) — Note that some links may require registration or subscription. Silintan capsules, a dietary supplement marketed for joint and body aches, have been recalled due to the presence of meloxicam, a nonsteroidal anti-inflammatory… (MedPage Today) — Note that some links may require registration or subscription. Silintan capsules, a dietary supplement marketed for Read More
How Ozempic and Wegovy are quietly cutting America’s food billsHow Ozempic and Wegovy are quietly cutting America’s food bills
Weight-loss drugs like Ozempic and Wegovy are changing how Americans spend money on food. A large Cornell study found households cut grocery spending by over 5% within six months, with even bigger drops at fast-food restaurants. Snack foods and sweets saw the steepest declines, while only a few categories like yogurt and fruit rose slightly. Read More